Clinical Trial: Glycine Treatment of Prodromal Symptoms
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Glycine Treatment of Prodromal Symptoms
Brief Summary: This is an open label trial of the NMDA agonist glycine used alone for symptoms that appear to be prodromal for schizophrenia in adolescents and young adults.
Detailed Summary:
Sponsor: Yale University
Current Primary Outcome: Scale Of Prodromal Symptoms total score [ Time Frame: 8 weeks ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Yale University
Dates:
Date Received: December 20, 2005
Date Started: July 2002
Date Completion:
Last Updated: March 28, 2012
Last Verified: March 2012